Mitochondrial Dysfunction in Inflammatory Skin Diseases: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies
Drug Development Research · 2026
DOI: 10.1002/ddr.70221 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Development Research, 2026. Verfasst von Mei Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Zibo Central Hospital, Zibo, Shandong, China. Hauptthemen laut MEDLINE: Mitochondria, Skin Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 104 Literaturangaben.
Abstract (Originalsprache)
Mitochondrial dysfunction critically underpins the pathogenesis of inflammatory skin diseases such as psoriasis, vitiligo, atopic dermatitis, and impaired wound healing. This comprehensive review synthesizes recent evidence to elucidate mechanisms, including compromised bioenergetics, excessive reactive oxygen species (ROS), mitochondrial DNA (mtDNA) damage, and aberrant mitochondrial dynamics. Distinct from prior work, this analysis uncovers novel findings: mtDNA acts as a damage‐associated molecular pattern, activating cyclic GMP‐AMP synthase–stimulator of interferon genes (cGAS‐STING) pathways to drive type I interferon in vitiligo and IL‐17A in psoriasis; succinate‐mediated immune‐metabolic signaling amplifies type 2 inflammation in atopic dermatitis; and subclinical mitochondrial impairments in non‐lesional skin serve as early indicators of disease susceptibility across these conditions. Preclinical studies have shown that emerging therapies, including antioxidants (e.g., NMN), mitochondrial modulators (e.g., SS31), senotherapeutics, and mitochondrial transplantation, are promising strategies for restoring cellular function. Future research should focus on multi‐omics to dissect mitochondrial‐epigenetic interactions, validate mitochondrial metabolites like succinate as diagnostic biomarkers, and explore synergistic combination therapies. This integrative framework of mitochondrial‐driven pathology provides fresh perspectives to advance diagnostic and therapeutic innovation in dermatology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Zibo Central Hospital, Zibo, Shandong, China.
ORCID-Profile: Jie Shen
Zitieren
APA
Li, M., Zhao, G., Zhao, G. W., & Shen, J. (2026). Mitochondrial Dysfunction in Inflammatory Skin Diseases: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies. Drug Development Research. https://doi.org/10.1002/ddr.70221
Vancouver
Li M, Zhao G, Zhao GW, Shen J. Mitochondrial Dysfunction in Inflammatory Skin Diseases: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies. Drug Development Research. 2026. doi:10.1002/ddr.70221
BibTeX
@article{Li2026,
author = {Li, Mei and Zhao, Guowei and Zhao, Guo-Wei and Shen, Jie},
title = {Mitochondrial Dysfunction in Inflammatory Skin Diseases: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies},
journal = {Drug Development Research},
year = {2026},
doi = {10.1002/ddr.70221}
}
EUVIMED